Jade Biosciences (JBIO) Minority Interest (2020 - 2021)
Jade Biosciences (JBIO) posted Minority Interest of $4.0 million for Q2 2021, little changed on a QoQ basis from $4.0 million in Q4 2020.
Jade Biosciences (JBIO) Minority Interest (2020 - 2021) Analysis & Trends
Jade Biosciences' Minority Interest history runs 2 years deep, the most recent figure standing at $4.0 million for Q2 2021.
- Quarterly Minority Interest changed N/A year-over-year to $4.0 million in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $4.0 million (changed N/A YoY) and the FY2020 annual result came in at $4.0 million, changed N/A from the prior year.
- Minority Interest was $4.0 million for Q2 2021 at Jade Biosciences, roughly flat from $4.0 million in the prior quarter.
- Across five years, Minority Interest topped out at $4.0 million in Q4 2020 and bottomed at $4.0 million in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Jade Biosciences | 16.25 Mn | 16.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 4.00 Mn |
| Dec 31, 2020 | 4.00 Mn |